chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Issues with my gum; Itching; sore; redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore) and GINGIVAL DISCOMFORT (Issues with my gum) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.  Concomitant products included PANTOPRAZOLE, LINACLOTIDE (LINZESS), SIMVASTATIN, LORAZEPAM and FAMOTIDINE for an unknown indication.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore) and GINGIVAL DISCOMFORT (Issues with my gum). At the time of the report, PRURITUS (Itching), ERYTHEMA (Redness), PAIN IN EXTREMITY (Sore) and GINGIVAL DISCOMFORT (Issues with my gum) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Pantoprazole,Lizzness,Simvastatin,Lorazepam Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow up report received on 24-June-2021 event outcome updated
Showed symptoms of COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Showed symptoms of COVID) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No mediacl history was provided by the reporter.  Concomitant products included LOSARTAN, EZETIMIBE (ZETIA), VITAMIN B COMPLEX, COLECALCIFEROL (VITAMIN D 3), ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN C [ASCORBIC ACID] and ZINC for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced COVID-19 (Showed symptoms of COVID) (seriousness criterion medically significant). At the time of the report, COVID-19 (Showed symptoms of COVID) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment details included Patient took guaifenesin (Mucinex) for her symptoms. Company Comment: Causality for event COVID-19 is not applicable.; Sender's Comments: Causality for event COVID-19 is not applicable
15 year old received the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received the Moderna COVID-19 vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 047C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received the Moderna COVID-19 vaccine). On 30-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up information contains No Newinformation. On 29-Jun-2021: Follow-up information contains No NewInformation On 12-Jul-2021: Followup received contains second dose details.
Hand Flapping, Seizure like episodes with Palsy like movements with his hands and head in the car while driving and when relaxed on the couch. They usually last 5-30 seconds but he can have 20 in a matter of 30 minutes. Every time we are in the car he still have these movements with his arms and hands. It seems to always happen in the car, rarely anywhere else except for the couch after waking up from a nap or about to fall asleep. Some days are better than others. When he is having an episode we notice he goes into a staring like fog. We can snap him out of it sometimes but occasionally it takes him a few seconds to snap out of it.
Pt had Pentacel injection R upper thigh, PCV13 injection L upper thigh and Rotateq (oral) vaccinations done/given @ 3 pm 1-31-12. 40 mg Tylenol given PO prior to shots. 0 Problems 15 min p injections. Later that evening (8 pm) mother said child's legs were both red, with bright red spots and hard lumps under injection sites - warm to touch. Next day 2-1-12 - temp elevations up to 99.8, increased restlessness. Legs still red, painful to touch. Next day 2-2-12 - fever of 101.5 - brought down by Tylenol. Red bumps L thigh from hip to knee, sm. amt R thigh. 0 fevers. 0 painful to palpation per mom 2-3-12.
My Pap smear results returned abnormal months after receiving this vaccine. Then In 2017 I began losing ability to control nervous system. This began with my legs and moved to my arms after sometime.
Injection site was LUA, medial top of tricep, just lateral to the L axilla area. There is pain at the injection site, an edematous area a few cm's into the axilla from the injection site accompanied with pain, numbness and tingling in the axilla, down the arm and into the fingers. I wanted to take a wait and see approach due to I am not familiar with this vaccine, and the issues I am having would have hopefully resolved but, sadly, they have not. I am going to follow up with my medical provider in the next couple of days.
Pt received vaccine at 1611, at 1642 pt reported painfull swallowing. Administered Benadryl 50 mg PO. pt in high risk obs. At 1710 pt reported symtoms were better. Pt was instructed on use of Benadryl q 4-6 hours as needed and s/s to report , and symtoms to dial 911 for. Pt verbalized understanding. Offered to observe pt for an additional 30 min and Pt declined. Pt was not driving herself home. Pt left at 1715.  RN
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in a 72-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Date the vial was initially stored in the refrigerator reported as unknown. Total of 173 doses/vials were given for LOT 070H21A.  The vial did not undergo any temperature excursions.  Treatment information was not provided.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow up received included non significant information of secondary reporter was added.
The patient received her first dose of the Pfizer Covid vaccine and was out in the waiting area and then returned to the pharmacy approximately 10 minutes later to report that it felt like her throat was tightening. I had her sit in the vaccination booth and asked her if she was having any other symptoms like difficulty breathing. She said that she did not. I said that we would have her sit for a bit while I observed her and see how her symptom progressed. I looked at her face and legs and it did not appear as if she had any signs of rash or hives. Every minute or so I asked how she was feeling and she said that it seemed like her throat was tightening more. At about 5 minutes, since her initial complaint and because it seemed like her throat tightening was getting worse and she seemed more panicked, I told her that I would go ahead and have EMS called and administer an epipen injection to her. She wanted me to go ahead with this. I administered one dose. Shortly after, EMS arrived and assessed her and she made the decision to go to the hospital with them.
Moderna Dose 1 2/16/21 (lot NA) Moderna Dose 2 3/19/21 (lot NA) Moderna Dose 3 11/4/21 (077C21B) COVID Positive 1/6/22  1/6/22: The patient is 75-year-old female with a past medical history of O2 dependent COPD and follows with Dr., HTN, severe anxiety and follows with a psychologist on Prozac and Xanax, hypothyroid, and RA. She presents to the ER with c/o increasing shortness of breath for last 3 days. Patient is fully vaccinated against COVID-19 and has received her booster.  X-ray showing bilateral pneumonia and has a pending COVID-19 test. Patient was treated with Rocephin, DuoNeb, Solu-Medrol and IV fluid. She also reported increased anxiety and was treated with Xanax in ER.   During my examination in ER patient was resting comfortably in her bed and denies fevers, chills, nausea, vomiting, chest pain, headaches, abdominal pain, palpitation, headaches numbness and tingling. She is from home with her husband who is her primary caretaker. Patient uses 2 L at rest and 3 L activities and sleep. ED blood work unremarkable and she is currently 4 L O2 with sats around 91%. Patient will be admitted into the medical unit will be treated for community-acquired pneumonia. Explained plan of care with the patient she is agreeable to stay in hospital for further management. Per patient's request will call her husband for updates.  1/11/22: Patient is a 75-year-old female with history of severe anxiety, hypertension, rheumatoid arthritis, and chronic hypoxic respiratory failure secondary to advanced COPD who was admitted on 1/6/2022 with bilateral COVID pneumonia and acute on chronic hypoxic respiratory failure. She was also noted to have intermittent AFib RVR which quickly transitioned back to sinus rhythm.  The patient was admitted to the medical floor and was started on Remdesivir, Azithromycin, Rocephin, and dexamethasone.  She has slowly improved over the last several days.  She is back to her home oxygen need which is 3 L at rest and with activity.  The patient was evaluated by Physical therapy and they felt as though she would be able to safely go home with VNA services.  The patient was agreeable to palliative care and an Alternatives referral for extra help at home. These were both sent yesterday.  The patient this morning reports that she is feeling much better.  She is a little nervous about going home, but after discussing it, she will take it slow and steady.  She denies shortness of breath at rest, but does still report some dyspnea on exertion.  She denies chest pain or palpitations.  She is currently in sinus rhythm.  The patient was started on Toprol XL and Eliquis for her AFib.  She should follow-up with her cardiologist in 1-2 weeks and we have discussed this.
Pt devel fever which didn't respond to APAP every 4 hrs; @ 7PM pt fever was 105 & cried whenever  nursed; taken to ER pt had an ear infect; more APAP given, cold compresses to forehead & ATB started;
Tingling at the tip of the tongue and swelling of both lips. Diagnosis: Delayed hypersentivity reaaction to the Flu vaccine.
Around 0530 on 2/25/2021 reported heart started to race.  Received second dose of vaccine on 2/24/2021.  Stated he did not feel good but the heart racing started the next morning.  Came into medical for BP check.  HR 159, ECG done, SVT at 153.  Dr. able to convert to normal HR with vagal maneuver.
Rash; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "recovered", described as "Rash". Therapeutic measures were taken as a result of rash.  The lot number for COVID-19 Vaccine - Manufacturer Unknown was not provided and will be requested during follow up.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: UVEITIS (medically significant), outcome "unknown", described as "severe case of Uveitis after booster"; PALPITATIONS (non-serious), outcome "unknown", described as "heart palpitations after booster". The lot number for bnt162b2 was not provided and will be requested during follow up.
Red itchy eyes with mucus in them.  Eyes bloodshot.  Nausea, chills, throat appeared to swell and a sore throat. Urge to vomit and did.  Very tired and simply did not feel well.  Needed to sleep.  Pounding headache.
Received Pfizer vaccines on 2/6/21, 2/27/21, 9/28/21. Tested positive for COVID 19 by PCR on 10/6/21 admitted to Hospital on 10/7/21 with fever, malaise, myalgia, abd pain, diarrhea, altered mental status.
Swelling of the arm, red rash, itching, lump at site of injection lasting 10 days.
01/18/08-Flu-like muscular pains, fatigue, low fever.  01/19/08-Rash on back of hands.  01/20/08-Rash spread to wrists & arms.  01/21/08-Rash spread to thighs, legs & ankles.  01/27/08-Welts in rash on upper thighs.
Severe Vertigo, Nausea, Dizziness,  at times  unable to walk it is so bad.
Right thigh red/warm to touch, raised area 14.5cm w x 8cm l
Information has been received from a nurse concerning a 20 year old female patient who in June 2009 was vaccinated IM with the first 0.5 ml dose of GARDASIL. Two weeks after the vaccination the patient developed severe headaches, lightheadedness and nausea. The patient experienced these symptoms for 2 months during which time she was on muscle relaxers and pain medication. The patient had sought medical attention, treated by physician. The patient recovered two months after the onset of symptoms. The patient decided to discontinue the series. Severe headaches, lightheadedness and nausea were considered to be disabling. It was reported that the nurse felt muscle relaxants could be disabling. On 15-SEP-2009 follow-up information received from a registered nurse indicated that a female patient with a medical history of pulmonary stenosis at the age of two which required "balloon surgery" (exact date not reported) and Lasix eye surgery (date not provided) who was vaccinated with the first and only dose of GARDASIL (Lot#658271/0558X) on 11-JUN-2009. There was no listing of any concomitant medications and the patient did not receive any other vaccinations at the time of her GARDASIL vaccination. When the patient did not show up for her second appointment, the nurse called her to follow-up. It was at this time that the patient reported to the nurse that she had developed the severe headaches, lightheadedness and nausea after her first GARDASIL vaccination. The nurse reported that she did not say that she felt the muscle relaxants were disabling. The nurse also said that the patient did not miss work or school due her muscle relaxant use. The nurse confirmed that the patient told her that it took two months for the patient's symptoms to resolve, but they had indeed resolved (date was not known by the nurse). The nurse further noted that the patient would not be finishing the GARDASIL series and she was not sure if they would see the patient again. Additional information is not expected.
A nurse reported that a female subject of unspecified age did not respond to immunization with hepatitis B vaccine recombinant (Engerix-B).  The subject's medical history, concurrent conditions, and concurrent medications were not reported.  On unspecified dates, the subject received her first injection (Lot # ENG525A6) and second injection (Lot # ENG5287A6) of Engerix-B.  On 11/05/02, the subject received her third injection (Lot # ENG5312A6) of Engerix-B.  An unspecified titer measured on 05/10/03 was "negative".  Comment: The lot number provided for the first injection of Engerix-B is not a complete lot #.
Fever 5-25-11 - 5-26-11 with redness at site of MMRV. Fatigue, balance issues & fussiness onset in same time period and continue at present.
COVID 19 Treatment/He has had all four doses of the Pfizer COVID vaccine; COVID 19 Treatment/He has had all four doses of the Pfizer COVID vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 at 13:00 as dose 1, single (Lot number: EN6198), in left arm, on 18Mar2021 at 13:00 as dose 2, single (Lot number: ER6213), in left arm, on 19Aug2021 at 14:00 as dose 3 (booster), single (Lot number: FC3181), in left arm and on 11Apr2022 at 14:00 as dose 4 (booster), single (Lot number: FC9943) at the age of 60 years, in left leg for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing), notes: Other medical history: Psoriatic arthritis. Concomitant medication(s) included: COSENTYX, start date: 02May2022; VALTREX, start date: 03Jan2022; LINZESS, start date: 03Jan2022; ROSUVASTATIN, start date: 06Dec2021; ENSTILAR, start date: 07Feb2022; MOMETASONE, start date: 06Dec2021; BABY ASPIRIN, start date: 03Jan2022; MUCINEX D, start date: 03Jan2022; VITAMIN D [VITAMIN D NOS], start date: 03Jan2022; FLORASTOR [SACCHAROMYCES BOULARDII], start date: 03Jan2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment/He has had all four doses of the Pfizer COVID vaccine". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: I tested positive five days after the last dose of Paxlovid; (unspecified date) Positive, notes: I tested positive five days after the last dose of Paxlovid; (unspecified date) Positive, notes: I tested positive five days after the last dose of Paxlovid; (unspecified date) Positive, notes: I tested positive five days after the last dose of Paxlovid; (unspecified date) Positive, notes: I tested positive five days after the last dose of Paxlovid; (unspecified date) Positive, notes: Treatment of COVID-19; (09May2022) Negative, notes: He said that he felt fine, and tested negative 09May2022 and 10May2022; (10May2022) Negative, notes: He said that he felt fine, and tested negative 09May2022 and 10May2022. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient just recently finished taking Paxlovid last Sunday morning and experiencing Paxlovid rebound. Patient just started testing positive Covid again last night. He just wanted to make sure it was reported. He started Tuesday 10th finished 5th dose on Sunday. Patient felt fine and tested negative on the 9th and 10th and all of a sudden he got a runny nose and the cough seems to be gone and he testing positive again. Patient have read about it being isolated but he don't think it is so isolated.  No follow-up attempts are possible. No further information is expected.
About a month or month and a half later, all my joints, especially the ones that already had arthritis, got worse. My bones have deteriorating arthritis and it got worse. The pain its slowly gradually getting worse. I have been to the doctor, urgent care, and ER. They have done x-rays, CT scan, blood work. The CT scan showed I have more degeneration in my spine. I have never had a kidney stone and after the vaccine I had one. I am going to have surgery to take it out next month. Now I am taking Oxycodone. My hands feel like I have tendonitis all over them.
Patient received dose 2 of the Pfizer COVID vaccine (lot EW0179, exp 8/2021) at 1300. At 1318, patient was sitting in the observation area when he informed EMT  that he felt dizzy, warm, and had blurry vision. EMT  informed PHN who came over to assess. At 1320, vital signs: blood pressure 130/86, O2 97%, pulse 93, respirations 18. Patient reported blurry vision had resolved. EMT r offered to have patient lay down in the zero-gravity recliner but patient declined. Patient denied allergies, medical conditions, or taking medication. Patient reported eating breakfast and that he experienced no adverse reaction to dose 1. PHN encouraged patient to follow up with provider and when to contact 911. PHN  offered Benadryl but patient declined. At 1326, vital signs: blood pressure 124/82, pulse 97, O2 98%, respirations 18. Patient reported all symptoms had resolved. Patient stood up, reporting no dizziness or remaining symptoms. PHN  encouraged patient to wait for 30min since onset of symptoms, patient stated he was leaving. Patient left AMA, walking with steady gait at 1330.
Same response to Dose #1; Scleritis again developed in right eye, though less pain than before. As before, prescribed steroid eye drops and the symptoms are diminishing.  Before these vaccinations I've had no history of scleritis or other eye problems.